New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

A drug combo widely explored for anti-aging may actually damage the brain, according to new mouse research showing severe ...

The drug rilmenidine is usually taken to treat hypertension, but its powers appear to go far beyond that. In fact, research ...

A pair of surgical scissors from the Ming Dynasty tomb of physician Xia Quan. (Ling et al., Antiquity, 2026) This Week In ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

When Shania Collins was first approached about taking performance-enhancing drugs last year, it made her nervous enough to ...

Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease ...

(Guido Mieth/Moment/Getty Images) Around a third of people with major depressive disorder don't respond to standard ...

Fueled by multi-billion-dollar valuations and a deeper understanding of aging biology, the field is rapidly moving past the hype and into the clinic.